References
- Boulais PE, Frenette PS. Making sense of hematopoietic stem cell niches. Blood. 2015;125(17):1–15.
- Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. NatRevCancer. 2009;9(4):285–293.
- Meads MB, Hazlehurst LA, Dalton WS. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res. 2008;14(9):2519–2526.
- Lam HM, Vessella RL, Morrissey C. The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow. Drug Discov Today Technol. 2014;11:41–47.
- Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14(9):611–622.
- Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair–current views. Stem Cells. 2007;25(11):2896–2902.
- Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 2010;29(2):249–261.
- Barcellos-de-Souza P, Gori V, Bambi F, et al. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta. 2013;1836(2):321–335.
- Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557–563.
- Bergfeld SA, Blavier L, DeClerck YA. Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells. Mol Cancer Ther. 2014;13(4):962–975.
- Bernardo ME, Fibbe WE. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell. 2013;13(4):392–402.
- Krampera M. Mesenchymal stromal cell ‘licensing’: A multistep process. Leukemia. 2011;25(9):1408–1414.
- van der Pol E, Boing AN, Harrison P, et al. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64(3):676–705.
- Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066.
- Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol. 2013;200(4):367–371.
- Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289.
- Vader P, Breakefield XO, Wood MJ. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med. 2014;20(7):385–393.
- Tkach M, Thery C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232.
- Whiteside TL. Immune modulation of t-cell and nk (natural killer) cell activities by texs (tumour-derived exosomes). Biochem Soc Trans. 2013;41(1):245–251.
- Bobrie A, Thery C. Exosomes and communication between tumours and the immune system: are all exosomes equal? Biochem Soc Trans. 2013;41(1):263–267.
- Grange C, Tapparo M, Collino F, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011;71(15):5346–5356.
- Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011;71(11):3792–3801.
- Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through met. Nat Med. 2012;18(6):883–891.
- Dubois SG, Kalika Y, Lukens JN, et al. Metastatic sites in stage iv and ivs neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol. 1999;21(3):181–189.
- Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202–2211.
- Sohara Y, Shimada H, Minkin C, et al. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Res. 2005;65(4):1129–1135.
- Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for msc: the international society for cellular therapy position statement. Cytotherapy. 2005;7(5):393–395.
- Krampera M, Galipeau J, Shi Y, et al. Immunological characterization of multipotent mesenchymal stromal cells–the international society for cellular therapy (isct) working proposal. Cytotherapy. 2013;15(9):1054–1061.
- Kashyap R, Roucourt B, Lembo F, et al. Syntenin controls migration, growth, proliferation, and cell cycle progression in cancer cells. Front Pharmacol. 2015;6:241.
- Li J, Lee Y, Johansson HJ, et al. Serum-free culture alters the quantity and protein composition of neuroblastoma-derived extracellular vesicles. J Extracell Vesicles. 2015;4:26883.
- Boing AN, Van Der Pol E, Grootemaat AE, et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3:23430.
- Kowal J, Arras G, Colombo M, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113(8):E968–77.
- Ghossoub R, Lembo F, Rubio A, et al. Syntenin-alix exosome biogenesis and budding into multivesicular bodies are controlled by arf6 and pld2. Nat Commun. 2014;5:3477.
- Lotvall J, Hill AF, Hochberg F, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: A position statement from the international society for extracellular vesicles. J Extracell Vesicles. 2014;3:26913.
- Mathivanan S, Simpson RJ. Exocarta: A compendium of exosomal proteins and rna. Proteomics. 2009;9(21):4997–5000.
- Kim DK, Kang B, Kim OY, et al. Evpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles. J Extracell Vesicles. 2013;2:20384.
- Pathan M, Keerthikumar S, Ang CS, et al. Funrich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics. 2015;15(15):2597–2601.
- Ara T, Song L, Shimada H, et al. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells. Cancer Res. 2009;69(1):329–337.
- Weiler R, Meyerson G, Fischer-Colbrie R, et al. Divergent changes of chromogranin a/secretogranin ii levels in differentiating human neuroblastoma cells. FEBS Lett. 1990;265(1–2):27–29.
- Harris HE, Andersson U, Pisetsky DS. Hmgb1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012;8(4):195–202.
- Van Deun J, Mestdagh P, Sormunen R, et al. The impact of disparate isolation methods for extracellular vesicles on downstream rna profiling. J Extracell Vesicles. 2014;3:34858.
- Silverman AM, Nakata R, Shimada H, et al. A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma. Cancer Res. 2012;72(9):2228–2238.
- Chalmin F, Ladoire S, Mignot G, et al. Membrane-associated hsp72 from tumor-derived exosomes mediates stat3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010;120(2):457–471.
- Fabbri M, Paone A, Calore F, et al. Micrornas bind to toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA. 2012;109(31):E2110–E6.
- Liu S, Sun J, Lan Q. Glioblastoma microvesicles promote endothelial cell proliferation through akt/beta-catenin pathway. Int J Clin Exp Pathol. 2014;7(8):4857–4866.
- Svensson KJ, Christianson HC, Wittrup A, et al. Exosome uptake depends on erk1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem. 2013;288(24):17713–17724.
- Munn LL. Cancer and inflammation. Wiley Interdiscip Rev Syst Biol Med. 2016;9(8):DOI: 10.1002/wsbm.1370.
- Rossi JF, Lu ZY, Jourdan M, et al. Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015;21(6):1248–1257.
- Ara T, Nakata R, Sheard MA, et al. Critical role of stat3 in il-6-mediated drug resistance in human neuroblastoma. Cancer Res. 2013;73(13):3852–3864.
- Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. SeminOncol. 2002;29(6 Suppl 16):10–14.
- HaDuong JH, Blavier L, Baniwal SK, et al. Interaction between bone marrow stromal cells and neuroblastoma cells leads to a vegfa-mediated osteoblastogenesis. Int J Cancer. 2015;137(4):797–809.
- Sierra-Filardi E, Nieto C, Dominguez-Soto A, et al. Ccl2 shapes macrophage polarization by gm-csf and m-csf: identification of ccl2/ccr2-dependent gene expression profile. J Immunol. 2014;192(8):3858–3867.
- Wang J, Loberg R, Taichman RS. The pivotal role of cxcl12 (sdf-1)/cxcr4 axis in bone metastasis. Cancer Metastasis Rev. 2006;25(4):573–587.
- Vacchelli E, Eggermont A, Fridman WH, et al. Trial watch: immunostimulatory cytokines. Oncoimmunology. 2013;2(7):e24850.
- Paggetti J, Haderk F, Seiffert M, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015;126(9):1106–1117.
- Li X, Wang S, Zhu R, et al. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via nfkappab-tlr signaling pathway. J Hematol Oncol. 2016;9:42.
- De Vrij J, Maas SL, Kwappenberg KM, et al. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer. 2015;137(7):1630–1642.
- Al-Nedawi K, Meehan B, Kerbel RS, et al. Endothelial expression of autocrine vegf upon the uptake of tumor-derived microvesicles containing oncogenic egfr. Proc Natl Acad Sci U S A. 2009;106(10):3794–3799.
- Kucharzewska P, Christianson HC, Welch JE, et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013;110(18):7312–7317.
- Melo SA, Sugimoto H, O’Connell JT, et al. Cancer exosomes perform cell-independent microrna biogenesis and promote tumorigenesis. Cancer Cell. 2014;26(5):707–721.
- Challagundla KB, Wise PM, Neviani P, et al. Exosome-mediated transfer of micrornas within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015;107:7.
- Skog J, Wurdinger T, Van Rijn S, et al. Glioblastoma microvesicles transport rna and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–1476.
- Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–335.
- Fukaya Y, Shimada H, Wang LC, et al. Identification of gal-3 binding protein as a factor secreted by tumor cells that stimulates interleukin-6 expression in the bone marrow stroma. J Biol Chem. 2008;283(27):18573–18581.
- Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015;87:3–10.
- Carlsson L, Nilsson O, Larsson A, et al. Characteristics of human prostasomes isolated from three different sources. Prostate. 2003;54(4):322–330.
- Escrevente C, Grammel N, Kandzia S, et al. Sialoglycoproteins and n-glycans from secreted exosomes of ovarian carcinoma cells. Plos One. 2013;8(10):e78631.
- Block AS, Saraswati S, Lichti CF, et al. Co-purification of mac-2 binding protein with galectin-3 and association with prostasomes in human semen. Prostate. 2011;71(7):711–721.
- Hurwitz SN, Rider MA, Bundy JL, et al. Proteomic profiling of nci-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers. Oncotarget. 2016;7(52):86999–87015.